1,692
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Assessment of inhalation errors, training time and patient preference for DuoResp® Spiromax® and Symbicort® Turbuhaler® in patients with asthma and COPD

, , , , &
Article: 1833411 | Received 23 Jul 2019, Accepted 02 Oct 2020, Published online: 18 Oct 2020

References

  • GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet Respir Med. 2017;5:691–10.
  • Asher I, Pearce N. Global burden of asthma among children. Int J Tuberc Lung Dis. 2014;18: 1269–1278.
  • Ferkol T, Schraufnagel D. The global burden of respiratory disease. Ann Am Thorac Soc. 2014;11:404–406.
  • Global Initiative for Asthma. Global strategy for asthma management and prevention, 2018. [cited 2019 Jul 4]. Available from: www.ginasthma.org
  • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, 2018. [cited 2019 Jul 4]. Available from: www.goldcopd.org/gold-reports/
  • Al-Jahdali H, Ahmed A, Al-Harbi A. Improper inhaler technique is associated with poor asthma control and frequent emergency department visits. Allergy Asthma Clin Immunol. 2013;9: 8.
  • Crompton GK, Barnes PJ, Broeders M, et al. The need to improve inhalation technique in Europe: a report from the aerosol drug management improvement team. Respir Med. 2006;100:1479–1494.
  • Usmani OS, Lavorini F, Marshall J, et al. Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes. Respir Res. 2018;19:10.
  • Aydemir Y. Assessment of the factors affecting the failure to use inhaler devices before and after training. Respir Med. 2015;109:451–458.
  • Melani AS, Bonavia M, Cilenti V, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med. 2011;105:930–938.
  • van Beerendonk I, Mesters I, Mudde AN, et al. Assessment of the inhalation technique in outpatients with asthma or chronic obstructive pulmonary disease using a metered-dose inhaler or dry powder device. J Asthma. 1998;35:273–279.
  • Chapman KR, Love L, Brubaker H. A comparison of breath-actuated and conventional metered-dose inhaler inhalation techniques in elderly subjects. Chest. 1993;104:1332–1337.
  • Chrystyn H, Haahtela T. Real-life inhalation therapy – inhaler performance and patient education matter. Eur Respir Dis. 2012;8(1):11–18.
  • Giraud V, Allaert FA, Roche N. Inhaler technique and asthma: feasibility and acceptability of training by pharmacists. Respir Med. 2011;105:1815–1822.
  • Price D, Bosnic-Anticevich S; Briggs A (Inhaler Error Steering Committee). Inhaler competence in asthma: common errors, barriers to use and recommended solutions. Respir Med. 2013;107:37–46.
  • Brocklebank D, Ram F, Wright J. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. Health Technol Assess. 2001;5:1–149.
  • O’Connor BJ. The ideal inhaler: design and characteristics to improve outcomes. Respir Med. 2004;98(Suppl 1):S10–S16.
  • Atkins PJ. Dry powder inhalers: an overview. Respir Care. 2005;50:1304–1312.
  • Symbicort turbohaler 200/6 inhalation powder summary of product characteristics. Revised 2018 [cited 2019 Jul 4]. Available from: https://www.medicines.org.uk/emc/product/1327/smpc
  • Canonica GW, Arp J, Keegstra JR. Spiromax, a new dry powder inhaler: dose consistency under simulated real-world conditions. J Aerosol Med Pulm Drug Deliv. 2015;28:309–319.
  • DuoResp Spiromax Summary of product characteristics. Revised 2017 [cited 2019 Jul 4]. Available from: https://www.medicines.org.uk/emc/product/3324/smpc
  • GEMA. Spanis Asthma Guidelines. Guía Española para el Manejo del Asma (GEMA 4.0). Arch Bronconeumol. 2015 [cited 2019 Jul 4];51(S1):1–68. Available from: http://www.gemasma.com
  • GesEPOC. Spanish COPD guidelines (GesEPOC). 2017. Pharmacological treatment of stable chronic obstructive pulmonary disease. [cited 2019 Jul 4]. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0300289617300844
  • Voshaar T, Spinola M, Linnane P, et al. Comparing usability of NEXThaler® with other inhaled corticosteroid/long-acting beta2-agonist fixed combination dry powder inhalers in asthma patients. J Aerosol Med Pulm Drug Deliv. 2014;27:363–370.
  • Armitage JM, Williams SJ. Inhaler technique in the elderly. Age Ageing. 1988;17:275–278.
  • Jarvis S, Ind PW, Shiner RJ. Inhaled therapy in elderly COPD patients; time for re–evaluation? Age Ageing. 2007;36:213–218.
  • Nguyen TS, Nguyen TLH, Van Pham TT, et al. Pharmacists’ training to improve inhaler technique of patients with COPD in Vietnam. Int J Chron Obstruct Pulmon Dis. 2018;13:1863–1872.
  • Murray B, O’Neill M. Supporting self-management of asthma through patient education. Br J Nurs. 2018;27:396–401.
  • Geryk LL, Roberts CA, Carpenter DM. A systematic review of school-based interventions that include inhaler technique education. Respir Med. 2017;132:21–30.
  • Price DB, Román-Rodríguez M, McQueen RB, et al. Inhaler errors in the CRITIKAL study: type, frequency, and association with asthma outcomes. J Allergy Clin Immunol Pract. 2017;5:1071–1081.e9.
  • Capanoglu M, Dibek Misirlioglu E, Toyran M, et al. Evaluation of inhaler technique, adherence to therapy and their effect on disease control among children with asthma using metered dose or dry powder inhalers. J Asthma. 2015;52:838–845.